Organ Preservation Protocol in Oropharyngeal Cancer
Authors:
H. Binková; Z. Horáková
; E. Tóthová; R. Kostřica
Authors place of work:
Klinika ORL a chirurgie hlavy a krku LF MU a FN u sv. Anny, Brno
přednosta prof. MUDr. R. Kostřica, CSc.
Published in the journal:
Otorinolaryngol Foniatr, 59, 2010, No. 3, pp. 114-121.
Category:
Original Article
Summary
Introduction:
Organ preservation protocol (OPP) is one of treatment modalities for advanced resectable head and neck cancer. OPP’s goal is to maintain the organ and its physiological function without compromising the tumor control in comparison to surgery.
Goal of the study:
Analysis of survival rates and quality of life in OPP and surgery groups
Methods:
We retrospectively reviewed data from 190 patients with resectable stage III or IV oropharyngeal squamous cell carcinoma treated in our hospital from 2001 through 2008. The primary tumor was surgically treated in 123 patients, in 67 patients non-surgically. The treatment strategies were multimodal. They comprised combined chemoradiation (concurrent or neoadjuvant) followed by neck dissection or salvage surgery, if necessary.
Results :
Out of total 67 OPP patients, the treatment was completed by 62 (93%). 47 patients (70%) achieved complete response. 41 patients (61%) were healed by conservative treatment only without any surgery (organ preservation). The remainder, 6 patients, underwent salvage surgery. Survival rates in organ preserving group were as follows: OAS (overall survival) 49% and 41% at 3 and 5 years, respectively; DSS (disease-specific survival) 58% and 51% at 3 and 5 years, respectively; DFI (disease-free interval) 69% and 69%, respectively. OAS in surgical group was 64% and 53% at 3 and 5 years, respectively. DSS of 76% and 72% at 3 and 5 years, respectively, were observed. DFI of 80% and 77%, respectively, became obvious. In survival rates there was a statistically significant difference in survival rates in favor of surgery group: in OAS (Gehan-Wilcox p=0.015, Cox-Mantel p=0.013) and DSS (Gehan-Wilcox p=0.014, Cox-Mantel p=0.010).
To assess the impact of therapy on quality of life and function of preserved organ – tracheostomy and gastrostomy dependence and duration of their median use was analysed in both categories. In organ preserving group 20 patients (30%) needed tracheostomy for duration of 33 weeks in median. 10 patients (15%) required tracheostomy permanently. 41 patients (61%) required gastrostomy for 32 weeks in median, but 15 patients (22%) used gastrostomy permanently. In surgery group 79 patients (64%) needed tracheostomy, with median duration of 34 weeks. 23 patients (19%) needed permanent tracheostomy. 36 patients (29%) used gastrostomy for median time 30 weeks, but 13 patients (11%) remained gastrostomy-dependent.
Conclusion:
The survival rates (OAS, DSS, DFI) in the surgery group exceeded that of the organ preserving group statistically. No significant difference in quality of life was demonstrated between both categories on account of high toxicity and adverse effects of chemoradiation.
Key words:
oropharynx, cancer, organ preservation protocol, surgery, survival, quality of life.
Zdroje
1. Bernier, J., Cooper, J. S., Pajak, T. F., van Glabbeke, M., Bourhis, J., Forastiere, A., Ozsahin, E. M, Jacobs, J. R., Jassem, J., Ang, K. K., LefŹbvre, J. L.: Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck, 27, 2005, 10, s. 843-850.
2. Bourhis, J., Guigay, J., Temam, S., Lignin, J. P.: Chemo-radiotherapy in head and neck cancer. Annals of Oncology, 17, 2006, (Suplement 10), s. X39-X41.
3. De Bree, R., van der Putten, L., Brouwer, J., Castelijns, J. A., Hoekstra, O. S, Leemans, C. R.: Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging. Oral Oncol., 45, 2009, 4-5, s. 386-393.
4. Bumpous, J. M.: Surgical salvage of cancer of the oropharynx after chemoradiation. Curr. Oncol. Rep., 11, 2009, 2, s. 151-155.
5. Carroll, W. R., Locher, J. L., Canon, C. L., Bohannon, I. A., McColloch, N. L., Magnuson, J. S.: Pretreatment swallowing exercises improve swallow function after chemoradiation. Laryngoscope, 118, 2008, 1, s. 39-43.
6. Cmelak, A. J., Li, S., Goldwasser, M. A., Murphy, B., Cannon, M., Pinto, H., Rosenthal, D. I., Gillison, M., Forastiere, A. A.: Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. J. Clin. Oncol., 25, 2007, 1, s. 3971-3977.
7. Chao, K. S., Ozyigit, G., Blanco, A. I. et al.: Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int. J. Radiat. Oncol. Biol. Phys., 59, 2004, s. 43-50.
8. Chen, A. Y., Schrag, N., Hao, Y., Stewart, A., Ward, E.: Changes in treatment of advanced oropharyngeal cancer, 1985-2001. Laryngoscope, 117, 2007, 1, s. 16-21.
9. Denis, F., Garaud, P., Bardet, E., Alfonsi, M., Sire, C., Germain, T., Bergerot, P., Rhein, B., Tortochaux, J., Oudinot, P., Calais, G.: Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int. J. Radiat. Oncol. Biol. Phys., 55, 2003, 1, s. 93-98.
10. Dinh, V., Chua, L., Hustilko, P., Nissim, K., Savaraj, N.: Role of concurrent chemoradiotherapy in organ preservation for locally advanced head and neck cancer. J. Clin. Oncol., 27, 2009 (Suppl. abstr. 17044).
11. Forastiere, A. A., Goepfert, H., Maor, M., Pajak, T. F., Weber, R., Kortison, W., Glisson, B., Trotli, A., Ridge, J. A., Chao, C. Peters, G., Lee, D. J., Leaf, A., Ensley, J., Cooper, J.: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N. Engl. J. Med., 349, 2003, 22, s. 2091-2098.
12. Hitt, R.: Induction chemotherapy in head and neck cancer. Ann. Oncol., 17, 2006, Suppl. 10:x42-4. Review.
13. http://www.svod.cz/analyse.php?modul=incmor
14. Lee, P. N., Hamling, J.: The relation between smokeless tobacco and cancer in Northern Europe and North America. A commentary on differences between the conclusions reached by two recent reviews. BMC Cancer, 29, 2009, 9, s. 256.
15. Lim, Y. C., Hong, H. J., Baek, S. J., Park, J. H., Kim, G. E., Lee, C. G., Lew, D. H., Lee, W. J., Choi, E. C.: Combined surgery and postoperative radiotherapy for oropharyngeal squamous cell carcinoma in Korea: analysis of 110 cases. Int. J. Oral Maxillofac. Surg., 37, 2008, 12, s. 1099-1105.
16. Mowry, S. E., LoTempio, M. M., Sadeghi, A., Wang, K. H., Wang, M. B.: Quality of life outcomes in laryngeal and oropharyngeal cancer patients after chemoradiation. Otolaryngol Head Neck Surg., 135, 2006, 4, s. 565-570.
17. Pignon, J. P., le MaĒtre, A., Maillard, E., Bourhis, J.: MACH-NC Collaborative Group Collaborators (130).Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol., 92, 2009, 1, s. 4-14.
18. Sedaghat, A. R., Zhang, Z., Begum, S., Palermo, R., Best, S., Ulmer, K. M., Levine, M., Zinreich, E., Messing, B. P., Gold, D., Wu, A. A., Niparko, K. J., Kowalski, J., Hirata, R. M., Saunders, J. R., Westra, W. H., Pai, S. I.: Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoskope, 119, 2009, 8, s. 1542-1549.
19. Shiley, S. G., Hargunani, C. A., Skoner, J. M., Holland, J. M., Wax, M. K.: Swallowing function after chemoradiation for advanced stage oropharyngeal cancer. Otolaryngol Head Neck Surg., 134, 2006, 3, s. 455-459.
20. Shirazi, H. A., Sivanandan, R., Goode, R., Fee, W. E., Kaplan, M. J., Pinto, H. A., Goffinet, D. R., LeQT: Advanced-staged tonsillar squamous carcinoma: organ preservation versus surgical management of the primary site. Head Neck, 28, 2006, 7, s. 587-594.
21. Tachezy, R., Klozar, J., Rubenstein, L., Smith, E., Saláková, M., Mahelová, J., Ludvíková, V., Rotnáglová, E., Kodet, R., Hamříková, E.: Demographic and risk factors in patients with head and neck tumors, J. Med. Virol., 81, 2009, 5, s. 878-887.
22. Ukpo, O. C., Pritchett, C. V., Lewis, J. E., Weaver, A. L., Smith, D. I., Moore, E. J.: Human papillomavirus-associated oropharyngeal squamous cell carcinomas: primary tumor burden and survival in surgical patients.Ann. Otol. Rhinol. Laryngol., 118, 2009, 5, s. 368-373.
23. Wolf, G. et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N. Engl. J. Med., 324, 1991, 24, s. 1685-1690.
24. Worden, F. P., Kumar, B., Lee, J. S., Wolf, G. T., Cordell, K. G., Taylor, J. M., Urba, S. G., Eisbruch, A., Teknos, T. N., Chepeha, D. B., Prince, M. E., Tsien, C. I., D‘Silva, N. J., Yang, K., Kurnit, D. M., Mason, H. L., Miller, T. H., Wallace, N. E., Bradford, C. R., Carey, T. E.: Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. . J. Clin. Oncol., 26, 2008, 19, s. 3117-3119.
Štítky
Audiology Paediatric ENT ENT (Otorhinolaryngology)Článok vyšiel v časopise
Otorhinolaryngology and Phoniatrics
2010 Číslo 3
Najčítanejšie v tomto čísle
- Harmless Decongescents and Provident Application of Decongescents
- Vestibular Evoked Myogenic Potentials (VEMP) in Diagnostics of Vestibulopathies
- Pepsin and Weakly Acidic Esophageal Reflux
- Czech Version of the Quality of Life Questionnaire for Patients with Chronic Rhinosinusitis SNOT-22 (Sino-nasal Outcome Test)